TIDMRXB
Rex Bionics PLC
18 September 2015
Rex Bionics Plc
("Rex Bionics" or the "Company")
Rex Bionics Plc notes two legal cases awarding insurance funding
for wheelchair user access to the REX robotic walking device
-- First British recipient of a High Court damages settlement to pay for a REX
-- British Man awarded interim funding for an intensive course
of robot-assisted physiotherapy with REX, pending a final
settlement of the insurance claim
18 September, Rex Bionics Plc (AIM: RXB), the pioneer of the REX
Robot technology that enhances the mobility of wheelchair users,
notes two recent legal settlements -- awarding funding for the
purchase of a REX robot and funding for Robot-Assisted
Physiotherapy with REX.
These developments help to establish an important principle -
that individuals who experience a life-changing injury can secure
funding for access to this valuable technology.
Stewarts Law has announced that Ben Barnes, a 30 year-old man
who sustained a spinal cord injury in a road traffic accident, has
become the first recipient of a British High Court damages
settlement to pay for a REX, the robot that enhances the mobility
of wheelchair users.
Mr Barnes has settled his case, winning a damages settlement
including, among other items, approximately GBP550,000 to cover the
purchase of a REX robot, its replacements and associated costs. He
was represented by Ben Rogers, Partner at Stewarts Law LLP, who was
able to show that the REX would be beneficial to Ben Barnes' health
and sense of well-being.
Ben Rogers of Stewarts Law, commented: "This is a landmark award
of damages which means that Ben Barnes can purchase his own REX to
use at home."
Ben Barnes commented: "Since my car crash in 2011 I have been in
a wheelchair. I am delighted that the REX is included as part of my
settlement. Having been told I would never walk again, you can
understand my excitement when I first heard about REX and the
freedom it provides for people like me with paralysis. The initial
feeling of being upright and at eye level is priceless, not to
mention the health benefits. This truly is a life changing piece of
technology."
In a separate case, a man who sustained spinal cord damage as s
a result of alleged clinical negligence has been provided with
interim funding for an intensive course of robot-assisted
physiotherapy with REX, pending a final settlement of the insurance
claim.
Crispin Simon, Chief Executive Officer of Rex Bionics, said:
"These awards are an endorsement from the courts and from the
insurance industry, of the principle that the REX robot technology
can enable people with spinal cord injuries to remain healthy; and
to resume activities they may have thought were no longer available
to them."
"I believe everyone can see that REX is break-through technology
but it still needs to be paid for. There is a long way to go, but
these two cases are really significant milestones in our mission to
make REX available to everyone who needs it."
For further information please contact:
Rex Bionics Plc
Crispin Simon, Chief Executive Officer
+44 (0) 748 3 167851
Peter Worrall, Chief Financial Officer
+44 (0) 142 864 5416
Stifel Nicolaus Europe Limited (NOMAD and Broker)
Jonathan Senior/Giles Balleny
+44 (0) 20 7710 7600
Consilium Strategic Communications
Mary-Jane Elliott / Jessica Hodgson / Chris Welsh / Lindsey
Neville
rexbionics@consilium-comms.com
+44 (0) 203 709 5700
About Rex Bionics
Rex Bionics (AIM: RXB) is the UK AIM-listed pioneer of the REX
Robot that enhances the mobility of wheelchair users. Founded in
Auckland, New Zealand by two robotics engineers with first-hand
experience of wheelchair users and their needs, Rex Bionics is
working with physiotherapists to develop the practice of
Robot-Assisted Physiotherapy (RAP). In a session of RAP, REX lifts
patients from a sitting position into a robot-supported standing
position, allowing them to take part in a set of supported walking
and stretching exercises, designed by specialist
physiotherapists.
Wheelchair users are at risk of developing numerous medical
complications from extended periods of sitting. By enabling them to
spend more time standing, walking and exercising, REX may offer
significant health benefits, including improved sleep,
cardiovascular performance, maintenance of joint range, and a
reduction in spasm, pain, common abdominal problems and
prescription drug use. A programme of clinical trials is now under
way to evaluate these potential benefits.
REX has, up till now, been most commonly used by people with a
spinal cord injury, but has also been used by people who have
suffered a stroke or other traumatic brain injury; and people with
multiple sclerosis and muscular dystrophy. REX P, for use in the
home, enables users to walk and stand with their hands free -
providing more work and recreation options.
Rex Bionics has been listed on AIM since April 2014. REX is not
approved for At-Home use in the United States of America.
About Stewarts Law
The UK's largest litigation-only law firm specializes in
high-value and complex disputes. Stewarts Law's lawyers are
renowned for offering corporate clients and individuals innovative,
ground-breaking solutions. Its specialist departments include
aviation and travel, clinical negligence, commercial litigation,
competition litigation, divorce and family, employment,
international arbitration, investor protection litigation, personal
injury and tax litigation.
Each department has an international reputation for excellence.
With international strategic partnerships in place with law firms
around the world, Stewarts Law enables clients to take a global
approach to litigation. Its Personal Injury department is
consistently top-ranked by Chambers and Legal 500, the leading
directories in the legal industry.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAPKODKDBKBPCD
(END) Dow Jones Newswires
September 18, 2015 02:00 ET (06:00 GMT)
Rex Bionics (LSE:RXB)
Historical Stock Chart
From Jul 2024 to Aug 2024
Rex Bionics (LSE:RXB)
Historical Stock Chart
From Aug 2023 to Aug 2024